| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'14 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-61,510 | -30,240 | 23,562 | -111,560 | - | ||
Net loss | ||||||
- | - | - | - | -673 | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
83,456 | 47,593 | 44,356 | 42,850 | - | ||
Provision for bad debts | ||||||
63 | 1,208 | 308 | 1,052 | - | ||
Stock-based compensation | ||||||
2,934 | 2,804 | 1,886 | 3,250 | - | ||
Pension expense (income) | ||||||
0 | 17 | -153 | 188 | - | ||
Amortization of inventory fair value adjustment | ||||||
- | - | - | 30,377 | - | ||
Amortization of deferred financing costs | ||||||
2,600 | 2,476 | 2,368 | 2,275 | - | ||
Cash received on interest rate swap termination, net of non-cash interest income recognized | ||||||
0 | 3,684 | 0 | 0 | - | ||
Accretion of contingent consideration | ||||||
3,459 | 3,781 | 8,433 | 30,197 | - | ||
Change in fair value of contingent consideration | ||||||
-330 | -3,018 | -26,948 | -53,608 | - | ||
Deferred income taxes | ||||||
-21,631 | 1,154 | -12,515 | 13,792 | - | ||
Impairment of assets | ||||||
11,424 | 2,600 | 0 | 10,795 | - | ||
Goodwill impairment | ||||||
- | - | - | 62,400 | - | ||
Loss on sales of property | ||||||
-4 | 52 | -81 | -22 | - | ||
Other | ||||||
0 | 0 | -98 | -32 | - | ||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
321 | 5,362 | -5,981 | 4,101 | - | ||
Inventories | ||||||
388 | 1,581 | 2,496 | 764 | - | ||
Prepaid expenses and other current assets | ||||||
-2,087 | 652 | 5,176 | 7,788 | - | ||
Accounts payable | ||||||
6,499 | -10,955 | -13,889 | 6,357 | - | ||
Accrued expenses and other liabilities | ||||||
-9,239 | -4,175 | 18,432 | 2,341 | - | ||
Income taxes payable | ||||||
1,615 | -4,053 | 2,844 | -376 | - | ||
Other assets and liabilities | ||||||
663 | 2,217 | 11,783 | -2,780 | - | ||
Net cash provided in operating activities | ||||||
20,059 | 3,012 | 35,389 | 30,484 | - | ||
Prepaid expense | ||||||
- | - | - | - | 81 | ||
Due to related party | ||||||
- | - | - | - | 69 | ||
Franchise tax payable | ||||||
- | - | - | - | 180 | ||
Accrued expenses | ||||||
- | - | - | - | 80 | ||
Net cash (used in) provided by operating activities | ||||||
- | - | - | - | -424 | ||
Cash flows from investing activities: | ||||||
Cash flows from investing activities: | ||||||
Cash paid for property and equipment | ||||||
4,176 | 4,164 | 7,725 | 6,004 | - | ||
Proceeds from sale of property | ||||||
0 | 0 | 99 | 76 | - | ||
Acquisition of business, net of cash acquired | ||||||
0 | 0 | 18,192 | 0 | - | ||
Other investments | ||||||
250 | 1,587 | 11,132 | 600 | - | ||
Net cash used in investing activities | ||||||
-4,426 | -5,751 | -36,950 | -6,528 | - | ||
Cash and investments held in Trust Account | ||||||
- | - | - | - | 220,502 | ||
Cash flows from financing activities: | ||||||
Payment of Dow liabilities settlement | ||||||
0 | 10,000 | 10,000 | - | - | ||
Payment of Dow liabilities settlement | ||||||
0 | 10,000 | 10,000 | 0 | - | ||
Repayment of long-term debt | ||||||
6,285 | 6,096 | 4,015 | 4,250 | - | ||
Payments of contingent consideration | ||||||
0 | 6,132 | 0 | 0 | - | ||
Borrowings under revolving credit facility | ||||||
4,000 | 11,000 | 0 | 0 | - | ||
Repayments of revolving credit facility | ||||||
4,000 | 11,000 | 0 | 0 | - | ||
Settlement payment under Tax Receivables Agreement | ||||||
16,003 | 0 | 0 | - | - | ||
Effect of exchange rate on cash and cash equivalents | ||||||
- | - | - | 1,660 | - | ||
Proceeds from issuance of stock under employee stock purchase plan | ||||||
241 | 0 | 0 | - | - | ||
Repurchase of stock for treasury | ||||||
- | - | - | 1,488 | - | ||
Payment of withholding taxes related to stock-based compensation to employees | ||||||
- | - | - | 331 | - | ||
Net cash used in financing activities | ||||||
-22,047 | -22,228 | -14,015 | -6,069 | - | ||
Effect of exchange rate changes on cash and cash equivalents and restricted cash | ||||||
1,379 | -4,714 | 2,797 | - | - | ||
Net decrease in cash and cash equivalents and restricted cash | ||||||
-5,035 | -29,681 | -12,779 | - | - | ||
Supplemental disclosures of cash flow information: | ||||||
Net (decrease)/increase in cash | ||||||
- | - | - | - | 708 | ||
Cash paid for: | ||||||
Cash paid for: | ||||||
Cash paid for interest | ||||||
30,144 | 34,712 | 18,884 | - | - | ||
Cash paid for interest | ||||||
- | - | - | 24,560 | - | ||
Cash paid for income taxes | ||||||
2,642 | 6,949 | 3,257 | 3,095 | - | ||
Supplemental schedule of non-cash investing and financing activities: | ||||||
Accrued purchases of property and equipment | ||||||
71 | 607 | 1,422 | 815 | - | ||
Acquisition-related contingent consideration | ||||||
0 | 0 | 691 | 0 | - | ||
Settlement of Dow liabilities not resulting from a cash payment | ||||||
22,012 | 0 | 55,089 | 0 | - | ||
Reconciliation of cash and cash equivalents and restricted cash: | ||||||
Payment of offering costs | ||||||
- | - | - | - | 5,024 | ||
Proceeds from the sale of warrants to Sponsor | ||||||
- | - | - | - | 6,160 | ||
Proceeds from Public Offering | ||||||
- | - | - | - | 210,000 | ||
Proceeds from the underwriter's partial exercise of their over-allotment option | ||||||
- | - | - | - | 10,500 | ||
Net cash used in financing activities | ||||||
- | - | - | - | 221,635 | ||
Net (decrease) increase in cash and cash equivalents | ||||||
- | - | - | 19,547 | - | ||
Deferred underwriting fees | ||||||
- | - | - | - | 7,717 | ||